7Baggers
 Roflumilast sNDA Accepted for Plaque Psoriasis in Patients 2 to 5 Years  Dermatology Times Mon, 17 Nov 2025 16:38:34 GMT
 Why Arcutis Biotherapeutics Shares Are Climbing  TipRanks Mon, 17 Nov 2025 15:59:35 GMT
 Arcutis Biotherapeutics, Inc. (ARQT) Recently Broke Out Above the 20-Day Moving Average  Zacks Investment Research Mon, 17 Nov 2025 15:49:34 GMT
 FDA accepts Arcutis’ application for psoriasis cream in children By Investing.com  Investing.com Australia Mon, 17 Nov 2025 13:37:51 GMT
 arcutis completes enrollment in infant atopic dermatitis study by investing.com  Investing.com Nigeria Fri, 14 Nov 2025 02:37:00 GMT
 arcutis completes enrollment in infant atopic dermatitis study by investing.com  Investing.com Australia Thu, 13 Nov 2025 13:45:59 GMT
 Published on: 2025-11-12 03:26:24  newser.com Wed, 12 Nov 2025 09:26:24 GMT
 H.C. Wainwright Sticks to Their Buy Rating for Arcutis Biotherapeutics (ARQT)  The Globe and Mail Tue, 11 Nov 2025 01:24:47 GMT
 Arcutis biotherapeutics (ARQT) EVP Burnett sells $417k in shares  Investing.com Mon, 10 Nov 2025 23:08:27 GMT
 understanding the setup: (arqt) and scalable risk  news.stocktradersdaily.com Mon, 10 Nov 2025 13:34:03 GMT
 Does the 152% Price Jump in Arcutis Signal More Room to Run in 2025?  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 arcutis biotherapeutics executive vp burnett sells $156k in arqt stock  Investing.com Thu, 06 Nov 2025 00:04:28 GMT
 latha vairavan, arcutis biotherapeutics cfo, sells $2k in shares  Investing.com Thu, 06 Nov 2025 00:04:27 GMT
 Latha Vairavan, Arcutis Biotherapeutics CFO, sells $2k in shares  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 arcutis biotherapeutics joins leaders at dermatology conference  Traders Union Mon, 03 Nov 2025 19:00:34 GMT

Arcutis Biotherapeutics, Inc
(NASDAQ:ARQT) 

ARQT stock logo

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atop...

Founded: 2016
Full Time Employees: 53
CEO: Todd Franklin Watanabe  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends